Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.
Published August 30, 2023 · Recall initiated: August 14, 2023
Summary
FDA records drug Class III recall D-1103-2023, published August 30, 2023 and initiated August 14, 2023. Recalling firm: Baxter Healthcare Corporation; Status: Completed; Reported quantity: 13,502 vials; Lot: Lots: 3A004A, 3A004B, Exp 12/31/2024; 3B005A, Exp 1/31/2025. Class III means the product is not likely to cause adverse health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.
What to do
Voluntary: Firm initiated · Letter
Get an email if BENDAMUSTINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BENDAMUSTINE HYDROCHLORIDE
- Manufacturer
- Baxter Healthcare Corporation
- Distributor
- Nationwide in the U.S.A.
- Lot
- Lots: 3A004A, 3A004B, Exp 12/31/2024; 3B005A, Exp 1/31/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALugol's (Strong Iodine Solution USP), Each mL contains Iodine 0.05gm and potassium iodide 0.100gm, 8mL SingleAugust 30, 2023
- FDAAll Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.August 30, 2023
- FDAAstrinGyn (Ferric Subsulfate) Aqueous, 259 mg/g, 8 gm Single Use Vials, Manufactured for CooperSurgical,August 30, 2023
- FDASemaglutide/Cyanocobalamin 2mg/0.4mg/mL, 1mLvials, Tailor Made Compounding.August 30, 2023
- FDAactivator concentrate, Sodium Fluoride 0.96% in Activator Concentrate; 0.08% in diluted Activator Solution,August 30, 2023
- FDANAD+ 200mg/ml, 10ml vials, Tailor Made Compounding.August 30, 2023
Questions about this recall
Was Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01. recalled?
Yes. FDA published recall D-1103-2023 on August 30, 2023. Reported hazard: Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BENDAMUSTINE HYDROCHLORIDE.